An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Subscribe To Our Newsletter & Stay Updated
